SRIM
NVO

Saratoga Research & Investment Management’s Novo Nordisk NVO Stock Holding History

Saratoga Research & Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155M Sell
3,236,009
-200,320
-6% -$8.61M 8.49% 2
2026
Q1 		$126M Buy
3,436,329
+1,583,763
+85% +$75M 7.17% 4
2025
Q4 		$94.3M Sell
1,852,566
-1,141
-0.1% -$58.3K 4.94% 9
2025
Q3 		$103M Buy
1,853,707
+341,030
+23% +$20M 5.35% 7
2025
Q2 		$104M Buy
1,512,677
+58,517
+4% +$3.98M 5.59% 6
2025
Q1 		$101M Buy
1,454,160
+753,526
+108% +$62.2M 5.33% 7
2024
Q4 		$60.3M Sell
700,634
-7,885
-1% -$853K 3.04% 13
2024
Q3 		$84.4M Sell
708,519
-40,198
-5% -$5.36M 3.69% 11
2024
Q2 		$107M Sell
748,717
-35,074
-4% -$4.65M 4.86% 9
2024
Q1 		$101M Sell
783,791
-43,803
-5% -$5.21M 4.57% 8
2023
Q4 		$85.6M Sell
827,594
-62,571
-7% -$6.19M 3.95% 8
2023
Q3 		$81M Sell
890,165
-25,219
-3% -$2.22M 3.95% 9
2023
Q2 		$74.1M Sell
915,384
-23,364
-2% -$1.91M 3.41% 14
2023
Q1 		$74.7M Sell
938,748
-417,926
-31% -$29.6M 3.55% 12
2022
Q4 		$91.8M Sell
1,356,674
-41,144
-3% -$2.41M 4.54% 6
2022
Q3 		$69.6M Sell
1,397,818
-15,974
-1% -$856K 3.68% 12
2022
Q2 		$78.8M Sell
1,413,792
-158,800
-10% -$8.81M 3.9% 8
2022
Q1 		$87.3M Sell
1,572,592
-24,316
-2% -$1.25M 3.8% 10
2021
Q4 		$89.4M Sell
1,596,908
-73,448
-4% -$3.98M 3.81% 9
2021
Q3 		$80.2M Sell
1,670,356
-805,466
-33% -$38.9M 3.7% 11
2021
Q2 		$104M Buy
2,475,822
+30,974
+1% +$1.2M 4.89% 5
2021
Q1 		$82.4M Buy
2,444,848
+109,454
+5% +$3.9M 4.17% 9
2020
Q4 		$81.6M Buy
2,335,394
+49,350
+2% +$1.71M 4.37% 8
2020
Q3 		$79.4M Sell
2,286,044
-88,012
-4% -$2.93M 4.76% 6
2020
Q2 		$77.7M Sell
2,374,056
-667,444
-22% -$21.3M 4.91% 7
2020
Q1 		$91.5M Sell
3,041,500
-23,026
-0.8% -$686K 6.35% 2
2019
Q4 		$88.7M Sell
3,064,526
-26,874
-0.9% -$744K 5.32% 5
2019
Q3 		$79.9M Sell
3,091,400
-7,538
-0.2% -$191K 5.16% 6
2019
Q2 		$79.1M Buy
3,098,938
+78,246
+3% +$1.93M 4.97% 7
2019
Q1 		$79M Buy
3,020,692
+146,108
+5% +$3.59M 5.39% 6
2018
Q4 		$66.2M Sell
2,874,584
-103,450
-3% -$2.3M 5.25% 7
2018
Q3 		$70.2M Sell
2,978,034
-65,158
-2% -$1.59M 4.73% 7
2018
Q2 		$70.2M Sell
3,043,192
-54,166
-2% -$1.29M 5.04% 7
2018
Q1 		$76.3M Buy
3,097,358
+76,646
+3% +$2.01M 5.58% 6
2017
Q4 		$81.1M Buy
3,020,712
+29,600
+1% +$753K 5.67% 4
2017
Q3 		$72M Buy
2,991,112
+57,106
+2% +$1.29M 5.5% 6
2017
Q2 		$62.9M Buy
2,934,006
+141,604
+5% +$2.86M 5% 7
2017
Q1 		$47.9M Buy
2,792,402
+254,872
+10% +$4.44M 3.98% 9
2016
Q4 		$45.5M Buy
2,537,530
+140,132
+6% +$2.54M 4.11% 9
2016
Q3 		$49.9M Buy
2,397,398
+802,534
+50% +$19.9M 4.27% 8
2016
Q2 		$42.9M Buy
1,594,864
+87,112
+6% +$2.39M 3.85% 10
2016
Q1 		$40.9M Buy
1,507,752
+334,652
+29% +$8.97M 3.6% 10
2015
Q4 		$34.1M Sell
1,173,100
-28,684
-2% -$794K 3.3% 14
2015
Q3 		$32.6M Buy
1,201,784
+1,494
+0.1% +$42.3K 3.27% 14
2015
Q2 		$32.9M Sell
1,200,290
-68,474
-5% -$1.92M 3.13% 15
2015
Q1 		$33.9M Sell
1,268,764
-166,466
-12% -$3.83M 3.16% 16
2014
Q4 		$30.4M Sell
1,435,230
-31,250
-2% -$698K 2.81% 19
2014
Q3 		$34.9M Sell
1,466,480
-84,370
-5% -$1.94M 3.45% 16
2014
Q2 		$35.8M Sell
1,550,850
-116,720
-7% -$2.58M 3.57% 15
2014
Q1 		$38.1M Buy
1,667,570
+29,300
+2% +$624K 3.88% 14
2013
Q4 		$30.3M Buy
1,638,270
+181,350
+12% +$3.16M 3.22% 16
2013
Q3 		$24.7M Sell
1,456,920
-35,020
-2% -$589K 2.9% 17
2013
Q2 		$23.1M Buy
+1,491,940
New +$24.8M 2.72% 17

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Saratoga Research & Investment Management's NVO Position: Q2 2026 in Review

Saratoga Research & Investment Management reduced its Novo Nordisk (NVO) stake by 5.8% in Q2 2026, selling an estimated $8.61M and leaving 3,236,009 shares worth $155M. The position accounts for 8.49% of the portfolio, ranked #2.

Saratoga Research & Investment Management first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. 884 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Saratoga Research & Investment Management held 3,236,009 shares of Novo Nordisk worth $155M as of Q2 2026.
  • Saratoga Research & Investment Management sold 200,320 Novo Nordisk shares in Q2 2026, an estimated $8.61M.
  • Novo Nordisk made up 8.49% of Saratoga Research & Investment Management's portfolio in Q2 2026, its #2 holding.
  • Saratoga Research & Investment Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • 884 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.